TuHURA Biosciences, Inc./NV Quarterly Common Stock, Shares Authorized from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
TuHURA Biosciences, Inc./NV quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q3 2024.
  • TuHURA Biosciences, Inc./NV Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 75M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 75M 0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 75M 0 0% Jun 30, 2024 10-Q 2024-11-14
Q1 2024 75M +69.5M +1264% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 75M +69.5M +1264% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 75M -200M -72.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 75M +69.5M +1264% Jun 30, 2023 10-K 2024-10-07
Q1 2023 5.5M -170M -96.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 5.5M -170M -96.9% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 275M +100M +57.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 5.5M -170M -96.9% Jun 30, 2022 10-K 2023-09-18
Q1 2022 175M +80M +84.2% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 175M +80M +84.2% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 175M +80M +84.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 175M +80M +84.2% Jun 30, 2021 10-K 2022-09-27
Q1 2021 95M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 95M 0 0% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 95M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 95M 0 0% Jun 30, 2020 10-K 2021-09-28
Q1 2020 95M +88M +1257% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 95M +25M +35.7% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 95M +25M +35.7% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 95M +88M +1257% Jun 30, 2019 10-K 2020-09-18
Q1 2019 7M -43M -86% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 70M +20M +40% Dec 31, 2018 10-Q 2019-02-11
Q3 2018 70M +20M +40% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 7M +2M +40% Jun 30, 2018 10-K 2019-09-09
Q1 2018 50M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 50M 0 0% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 50M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 5M -45M -90% Jun 30, 2017 8-K 2019-06-03
Q1 2017 50M -150M -75% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 50M -150M -75% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 50M -150M -75% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 50M 0 0% Jun 30, 2016 10-K 2017-09-27
Q1 2016 200M 0 0% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 200M 0 0% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 200M 0 0% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 50M -150M -75% Jun 30, 2015 10-K 2016-09-13
Q1 2015 200M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 200M 0 0% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 200M 0 0% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 200M 0 0% Jun 30, 2014 10-K/A 2015-11-16
Q1 2014 200M 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 200M 0 0% Dec 31, 2013 10-KT 2014-08-28
Q3 2013 200M +125M +167% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 200M 0 0% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 200M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 200M Dec 31, 2012 10-KT 2014-08-28
Q3 2012 75M Sep 30, 2012 10-Q/A 2012-12-20
Q2 2012 200M +125M +167% Jun 30, 2012 10-Q 2013-01-18
Q2 2011 75M Jun 30, 2011 10-K/A 2012-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.